PHENOTHIAZINE DRUGS AND METABOLITES - MOLECULAR-CONFORMATION AND DOPAMINERGIC, ALPHA ADRENERGIC AND MUSCARINIC CHOLINERGIC RECEPTOR-BINDING

被引：24

作者：

DAHL, SG ^{[1
]}

HOUGH, E ^{[1
]}

HALS, PA ^{[1
]}

机构：

[1] UNIV TROMSO,INST MATH & PHYS SCI,DEPT CHEM,N-9001 TROMSO,NORWAY

来源：

关键词：

D O I：

10.1016/0006-2952(86)90269-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1263 / 1269

页数：7

共 47 条

[1] ABERNATHY CO, 1977, P SOC EXP BIOL MED, V155, P474
[2] BYLUND DB, 1981, J PHARMACOL EXP THER, V217, P81
[3] CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140
[4] COURBEILS JL, 1972, THEORET CHEM ACTA, V24, P35
[5] HALOPERIDOL-H-3 BINDING TO DOPAMINE RECEPTORS IN RAT CORPUS STRIATUM - INFLUENCE OF CHLORPROMAZINE METABOLITES AND DERIVATIVES
CREESE, I
MANIAN, AA
PROSSER, TD
SNYDER, SH
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 47 (03) : 291 - 296
[6] DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS
CREESE, I
BURT, DR
SNYDER, SH
[J]. SCIENCE, 1976, 192 (4238) : 481 - 483
[7] CREESE I, 1978, NEUROTRANSMITTER REC, P141
[8] BINDING-AFFINITY OF LEVOMEPROMAZINE AND 2 OF ITS MAJOR METABOLITES TO CENTRAL DOPAMINE AND ALPHA-ADRENERGIC RECEPTORS IN THE RAT
DAHL, SG
HALL, H
[J]. PSYCHOPHARMACOLOGY, 1981, 74 (02) : 101 - 104
[9] DAHL SG, 1982, MOL PHARMACOL, V21, P409
[10] DAHL SG, 1976, EUR J PHARMACOL, V37, P241, DOI 10.1016/0014-2999(76)90031-5